Literature DB >> 24569452

Soluble TNFRp75 regulates host protective immunity against Mycobacterium tuberculosis.

Roanne Keeton, Nasiema Allie, Ivy Dambuza, Brian Abel, Nai-Jen Hsu, Boipelo Sebesho, Philippa Randall, Patricia Burger, Elizabeth Fick, Valerie F J Quesniaux, Bernhard Ryffel, Muazzam Jacobs.   

Abstract

Development of host protective immunity against Mycobacterium tuberculosis infection is critically dependent on the inflammatory cytokine TNF. TNF signals through 2 receptors, TNFRp55 and TNFRp75; however, the role of TNFRp75-dependent signaling in immune regulation is poorly defined. Here we found that mice lacking TNFRp75 exhibit greater control of M. tuberculosis infection compared with WT mice. TNFRp75-/- mice developed effective bactericidal granulomas and demonstrated increased pulmonary recruitment of activated DCs. Moreover, IL-12p40-dependent migration of DCs to lung draining LNs of infected TNFRp75-/- mice was substantially higher than that observed in WT M. tuberculosis-infected animals and was associated with enhanced frequencies of activated M. tuberculosis-specific IFN-γ-expressing CD4+ T cells. In WT mice, TNFRp75 shedding correlated with markedly reduced bioactive TNF levels and IL-12p40 expression. Neutralization of TNFRp75 in M. tuberculosis-infected WT BM-derived DCs (BMDCs) increased production of bioactive TNF and IL-12p40 to a level equivalent to that produced by TNFRp75-/- BMDCs. Addition of exogenous TNFRp75 to TNFRp75-/- BMDCs infected with M. tuberculosis decreased IL-12p40 synthesis, demonstrating that TNFRp75 shedding regulates DC activation. These data indicate that TNFRp75 shedding downmodulates protective immune function and reduces host resistance and survival; therefore, targeting TNFRp75 may be beneficial for improving disease outcome.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24569452      PMCID: PMC3973106          DOI: 10.1172/JCI45005

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

Review 1.  Immunology of tuberculosis.

Authors:  J L Flynn; J Chan
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

Review 2.  The TNF and TNF receptor superfamilies: integrating mammalian biology.

Authors:  R M Locksley; N Killeen; M J Lenardo
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 3.  The divergent role of tumor necrosis factor receptors in infectious diseases.

Authors:  D Schlüter; M Deckert
Journal:  Microbes Infect       Date:  2000-08       Impact factor: 2.700

4.  Fate of Mycobacterium tuberculosis within murine dendritic cells.

Authors:  K A Bodnar; N V Serbina; J L Flynn
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

5.  Correction of defective host response to Mycobacterium bovis BCG infection in TNF-deficient mice by bone marrow transplantation.

Authors:  M Jacobs; M W Marino; N Brown; B Abel; L G Bekker; V J Quesniaux; L Fick; B Ryffel
Journal:  Lab Invest       Date:  2000-06       Impact factor: 5.662

6.  Tumor necrosis factor receptor 2 plays a minor role for mycobacterial immunity.

Authors:  M Jacobs; N Brown; N Allie; K Chetty; B Ryffel
Journal:  Pathobiology       Date:  2000 Mar-Apr       Impact factor: 4.342

Review 7.  Tumor necrosis factor receptor-associated factor (TRAF) 2 and its role in TNF signaling.

Authors:  H Wajant; P Scheurich
Journal:  Int J Biochem Cell Biol       Date:  2001-01       Impact factor: 5.085

8.  Upregulation of p75 tumor necrosis factor alpha receptor in Mycobacterium avium-infected mice: evidence for a functional role.

Authors:  A Corti; L Fattorini; O F Thoresen; M L Ricci; A Gallizia; M Pelagi; Y Li; G Orefici
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 9.  The role of IL-10 in immune regulation during M. tuberculosis infection.

Authors:  P S Redford; P J Murray; A O'Garra
Journal:  Mucosal Immunol       Date:  2011-03-30       Impact factor: 7.313

10.  Lethal Mycobacterium bovis Bacillus Calmette Guérin infection in nitric oxide synthase 2-deficient mice: cell-mediated immunity requires nitric oxide synthase 2.

Authors:  I Garcia; R Guler; D Vesin; M L Olleros; P Vassalli; Y Chvatchko; M Jacobs; B Ryffel
Journal:  Lab Invest       Date:  2000-09       Impact factor: 5.662

View more
  24 in total

Review 1.  Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis.

Authors:  Anca Dorhoi; Stefan H E Kaufmann
Journal:  Semin Immunopathol       Date:  2015-10-05       Impact factor: 9.623

Review 2.  Mycobacterium Tuberculosis and Interactions with the Host Immune System: Opportunities for Nanoparticle Based Immunotherapeutics and Vaccines.

Authors:  Raymonde B Bekale; Su-Mari Du Plessis; Nai-Jen Hsu; Jyoti R Sharma; Samantha L Sampson; Muazzam Jacobs; Mervin Meyer; Gene D Morse; Admire Dube
Journal:  Pharm Res       Date:  2018-11-08       Impact factor: 4.200

3.  Control of Mycobacterial Infections in Mice Expressing Human Tumor Necrosis Factor (TNF) but Not Mouse TNF.

Authors:  Maria L Olleros; Leslie Chavez-Galan; Noria Segueni; Marie L Bourigault; Dominique Vesin; Andrey A Kruglov; Marina S Drutskaya; Ruth Bisig; Stefan Ehlers; Sahar Aly; Kerstin Walter; Dmitry V Kuprash; Miliana Chouchkova; Sergei V Kozlov; François Erard; Bernard Ryffel; Valérie F J Quesniaux; Sergei A Nedospasov; Irene Garcia
Journal:  Infect Immun       Date:  2015-06-29       Impact factor: 3.441

Review 4.  The balance between protective and pathogenic immune responses in the TB-infected lung.

Authors:  Ian M Orme; Richard T Robinson; Andrea M Cooper
Journal:  Nat Immunol       Date:  2015-01       Impact factor: 25.606

Review 5.  Cytokines and Chemokines in Mycobacterium tuberculosis Infection.

Authors:  Racquel Domingo-Gonzalez; Oliver Prince; Andrea Cooper; Shabaana A Khader
Journal:  Microbiol Spectr       Date:  2016-10

6.  TNFR2 Depletion Reduces Psoriatic Inflammation in Mice by Downregulating Specific Dendritic Cell Populations in Lymph Nodes and Inhibiting IL-23/IL-17 Pathways.

Authors:  Unnikrishnan M Chandrasekharan; Raminderjit Kaur; Jennifer E Harvey; Chad Braley; Vandana Rai; MacKenzie Lee; Nicholas de Windt; Jason Hsieh; Ritika Jaini; Defne Bayik; Rachel G Scheraga; Anthony P Fernandez; Paul E DiCorleto; M Elaine Husni
Journal:  J Invest Dermatol       Date:  2022-01-26       Impact factor: 7.590

7.  Interleukin-13-Overexpressing Mice Represent an Advanced Preclinical Model for Detecting the Distribution of Antimycobacterial Drugs within Centrally Necrotizing Granulomas.

Authors:  Kerstin Walter; Julia Kokesch-Himmelreich; Axel Treu; Franziska Waldow; Doris Hillemann; Nikolas Jakobs; Ann-Kathrin Lemm; Dominik Schwudke; Andreas Römpp; Christoph Hölscher
Journal:  Antimicrob Agents Chemother       Date:  2021-12-06       Impact factor: 5.938

8.  TNF-dependent regulation and activation of innate immune cells are essential for host protection against cerebral tuberculosis.

Authors:  Ngiambudulu M Francisco; Nai-Jen Hsu; Roanne Keeton; Philippa Randall; Boipelo Sebesho; Nasiema Allie; Dhirendra Govender; Valerie Quesniaux; Bernhard Ryffel; Lauriston Kellaway; Muazzam Jacobs
Journal:  J Neuroinflammation       Date:  2015-06-26       Impact factor: 8.322

9.  BCG therapy is associated with long-term, durable induction of Treg signature genes by epigenetic modulation.

Authors:  Ryan C Keefe; Hiroyuki Takahashi; Lisa Tran; Kacie Nelson; Nathan Ng; Willem M Kühtreiber; Denise L Faustman
Journal:  Sci Rep       Date:  2021-07-22       Impact factor: 4.379

10.  TNFRp75-dependent immune regulation of alveolar macrophages and neutrophils during early Mycobacterium tuberculosis and Mycobacterium bovis BCG infection.

Authors:  Avril Walters; Roanne Keeton; Antoinette Labuschagné; Nai-Jen Hsu; Muazzam Jacobs
Journal:  Immunology       Date:  2020-10-23       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.